Conclusions With the imminent availability of tirzepatide in the UK for treatment of people with type 2 diabetes, this review provides a timely and thought-provoking discussion of the possible future and wider impact of tirzepatide on diabetes complications, particularly once dedicated cardiovascular and renal studies are available
This helps us understand your unique needs and concerns
Were providing access to personalized care to women that is convenient and affordable. FAQs Does Hers take insurance
Xueding Z, Xiaoya W
CrossRef Naringin mitigates liver damage in a tissue-engineered liver of metabolic dysfunction-associated steatotic liver disease model by promoting autophagy via the mTOR-ULK1 pathway Jihui Jia, Yizhi Zhang, Jing Lin, Zhongping Duan, Yu Chen, Xiaohui Zhang Molecular Biology Reports .2025;[Epub] CrossRef Dietary supplementation with a designer metabolic modulator improves MASLD and associated anxiety in mice Agnese Segala, Gaia Favero, Emanuela Bottani, Alice Vetturi, Emirena Garrafa, Edoardo Parrella, Chiara Ruocco, Maurizio Ragni, Rita Rezzani, Enzo Nisoli, Alessandra Valerio Frontiers in Pharmacology .2025;[Epub] CrossRef From Steatosis to Immunosenescence: The Impact of Metabolic Dysfunction on Immune Aging in HIV and Non-HIV Populations Carlo Acierno, Maria Frontuto, Giulio Francesco De Stefano, Ana Erezanu, Andrea Limone, Simona Morella, Francesco Picaro, Donatella Palazzo, Michele Gilio Biomedicines .2025